Alphamethadol

From WikiMD's WELLNESSPEDIA

Alphamethadol

Alphamethadol is a synthetic opioid analgesic and a derivative of methadone. It is used primarily in the treatment of severe pain and as a maintenance therapy for opioid dependence. Alphamethadol is known for its long duration of action and is classified as a Schedule I controlled substance in the United States.

Chemical Structure and Properties[edit]

Alphamethadol is chemically similar to methadone, with the chemical formula C21H27NO. It is a racemic mixture, meaning it contains two enantiomers, which are mirror images of each other. The drug is typically administered in its hydrochloride salt form.

Pharmacology[edit]

Alphamethadol acts on the mu-opioid receptor, producing effects similar to those of other opioids, such as morphine and heroin. It has a high affinity for these receptors, leading to potent analgesic effects. The drug's long half-life allows for less frequent dosing compared to other opioids.

Medical Uses[edit]

Alphamethadol is used in the management of chronic pain and in opioid substitution therapy. It helps reduce withdrawal symptoms and cravings in individuals addicted to opioids. Due to its potency and potential for abuse, its use is highly regulated.

Side Effects[edit]

Common side effects of alphamethadol include:

Serious side effects may include respiratory depression, hypotension, and potential for addiction and abuse.

Regulation and Legal Status[edit]

In the United States, alphamethadol is classified as a Schedule I controlled substance under the Controlled Substances Act. This classification indicates that it has a high potential for abuse and no accepted medical use in treatment.

History[edit]

Alphamethadol was first synthesized in the mid-20th century as part of research into synthetic opioids. It was developed as an alternative to methadone for pain management and opioid dependence treatment.

See Also[edit]

Related Pages[edit]

Template:Opioid-analgesic-stub

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=Alphamethadol&oldid=5897132"